Ileostomy Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Ileostomy market studied was projected to grow with a CAGR of nearly 7.3% over the forecast period. The major factor attributing to the growth of the market is the increase in the incidence of intestinal diseases like intestinal cancer, diverticulitis, Crohn’s Disease, ulcerative colitis, and inflammatory bowel disease. According to the American Association for the Advancement of Science (AAAS), the number of people suffering from inflammatory bowel diseases is three times higher than previous estimates, with sufferers also at a higher risk of developing colorectal cancer, affecting over 3 million people across Europe. Furthermore, the growing popularity of drainable ostomy bags and increasing investments in product development is boosting the market growth. However, the gaining popularity of alternative procedures is the major drawback of market growth.

Key Market Trends

Cancer Segment is Dominating the Ileostomy Market.

The major share of the segment is attributed to the growing prevalence of gastrointestinal cancer cases. According to the American Society of Clinical Oncology (ASCO) for the year 2019 an estimated 10,590 adults; 5,610 men and 4,980 women in the United States will be diagnosed with small bowel cancer. The disease is diagnosed most often in people in their 60s and 70s. It is estimated that 1,590 deaths occur in the same year. As per the statistics, the increasing prevalence of cancer cases requiring the surgery grows the market growth propels. Furthermore, the increasing investment in research and development of the products by government initiatives and by the major players is also boosting the market growth.

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall market, throughout the forecast period. The market growth is due to the factors such as the presence of key players, high prevalence of in the region, established healthcare infrastructure are some of the key factors accountable for its large share in the market. Furthermore, beneficial government initiatives and an increase in the number of research partnerships are some of the drivers expected to increase market growth. In this region the United States has the maximum share due to supportive healthcare policies, the high number of patients, and a developed healthcare market.

Competitive Landscape

The Ileostomy market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are ConvaTec Inc., B. Braun Melsungen AG, Coloplast, Hollister Incorporated, Salts Healthcare, Flexicare Medical Ltd., Marlen Manufacturing, Smith & Nephew, 3M Healthcare.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support